Zobrazeno 1 - 10
of 87
pro vyhledávání: '"S. Wayne Mascarella"'
Autor:
Frank Ivy Carroll, Xing Zhang, Philip Abraham, S. Wayne Mascarella, Judith Flippen-Anderson, Jeffrey R. Deschamps
Publikováno v:
ARKIVOC, Vol 2010, Iss 4, Pp 96-103 (2010)
Externí odkaz:
https://doaj.org/article/cb966ffc5a9647429d7b89e659116c0d
Publikováno v:
Annals of the New York Academy of Sciences. 1489:48-77
During 2012-2018, the clandestine manufacture of new psychoactive substances (NPS) designed to circumvent substance control regulations increased exponentially worldwide, with concomitant increase in fatalities. This review focuses on three compound
Autor:
Herbert H. Seltzman, Jeffrey R. Deschamps, P. Anantha Reddy, S. Wayne Mascarella, Anita H. Lewin, Larry Brieaddy, F. Ivy Carroll, Scott E. Fix, Charles J. McElhinny, Gregory H. Imler
Publikováno v:
Bioorg Chem
Inconsistent results have been reported for the effects of the mitogen-activating extracellular kinase (MEK) inhibitor α-[amino(4-aminophenyl)thio]methylene-2-(trifluoromethyl)benzeneacetonitrile (SL 327) on ethanol-induced conditioned place prefere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a55f21d11bcceab0ad9b7d46b9c0e8
https://europepmc.org/articles/PMC8217309/
https://europepmc.org/articles/PMC8217309/
Autor:
Jeffrey R. Deschamps, Gregory H. Imler, F. Ivy Carroll, Larry Brieaddy, S. Wayne Mascarella, P. Anantha Reddy, Anita H. Lewin
Publikováno v:
ACS Chemical Neuroscience. 10:246-251
The demonstrated role of PKCβ in mediating amphetamine-stimulated dopamine efflux, which regulates amphetamine-induced dopamine transporter trafficking and activity, has promoted the research use of the selective, reversible PKCβ inhibitor (9 S)-9-
Autor:
Ann M. Decker, S. Wayne Mascarella, Chad M. Kormos, Timothy R. Fennell, James B. Thomas, Scott P. Runyon, Rodney W. Snyder, Hernán A. Navarro, F. Ivy Carroll, Pauline W. Ondachi
Publikováno v:
Journal of Medicinal Chemistry. 61:7546-7559
Animal pharmacological studies suggest that potent and selective κ opioid receptor antagonists have potential as pharmacotherapies targeting depression, anxiety, and substance abuse (opiates, alcohol, nicotine, cocaine). We recently reported lead co
Autor:
Jeffrey R. Deschamps, Moses G. Gichinga, Chad M. Kormos, S. Wayne Mascarella, F. Ivy Carroll, Gregory H. Imler, Scott P. Runyon, Hernán A. Navarro
Publikováno v:
The Journal of Organic Chemistry. 81:10383-10391
In order to gain additional information concerning the active conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine (1) class of opioid receptor antagonists, procedures were developed for the synthesis of structurally rig
Autor:
Pauline W. Ondachi, Hernán A. Navarro, Charles W. Luetje, Michael J. Marks, F. Ivy Carroll, Charles R. Wageman, Ana H. Castro, S. Wayne Mascarella, M. Imad Damaj
Publikováno v:
ACS Chemical Neuroscience. 7:1004-1012
In this study, we report the synthesis, nAChR in vitro and in vivo pharmacological properties of 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues (5, 6a,b, and 7a,b), which are analogues of our lead structure epibatidine. All of the analo
Autor:
Anita H, Lewin, Larry, Brieaddy, Jeffrey R, Deschamps, Gregory H, Imler, S Wayne, Mascarella, P Anantha, Reddy, F Ivy, Carroll
Publikováno v:
ACS chemical neuroscience. 10(1)
The demonstrated role of PKC
Autor:
Timothy R. Fennell, F. Ivy Carroll, Pauline W. Ondachi, James B. Thomas, Ann M. Decker, S. Wayne Mascarella, Hernán A. Navarro, Rodney W. Snyder, Scott P. Runyon, Chad M. Kormos
Publikováno v:
Journal of medicinal chemistry. 61(17)
Past studies have shown that it has been difficult to discover and develop potent and selective κ opioid receptor antagonists, particularly compounds having potential for clinical development. In this study, we present a structure—activity relatio
Autor:
Zhuo Ye, Charles W. Luetje, Pauline W. Ondachi, M. Imad Damaj, F. Ivy Carroll, Hernán A. Navarro, Ana H. Castro, S. Wayne Mascarella
Publikováno v:
Bioorganic & Medicinal Chemistry. 23:5693-5701
Over the last several years we have synthesized and studied the in vitro and in vivo nAChR pharmacological properties of epibatidine (4) analogs. In this study we report the synthesis, nAChR in vitro and in vivo pharmacological properties of 3'-(subs